Advertisement


Drug Controller General Of India Dcgi
India  /  Published 02.01.21

Homegrown Covaxin gets nod

Covaxin, the anti-coronavirus vaccine developed indigenously by India’s Hyderabad-based Bharat Biotech, has received restricted emergency use permission, with certain conditions, from an expert ...
By Our Bureau and Agencies in New Delhi

India  /  Published 31.12.20

Covid vaccine rollout in New Year: drug controller

The four key areas that will be addressed as part of interventions under the strategy are -- giving information on COVID-19 vaccines, addressing vaccine hesitancy, building vaccine eagerness along wit...
By Our Bureau, Agencies in New Delhi

India  /  Published 31.12.20

Vaccine: DCGI hint on rollout

India is likely to have a Covid-19 vaccine in the New Year, Drug Controller General of India V G Somani hinted on Thursday. Speaking at a webinar, Somani said the most important thing is that the ind...
By Our Bureau, Agencies in New Delhi

India  /  Published 06.12.20

Pfizer seeks India nod

Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its COVID-19 vaccine in the country, after its parent...
By Payal Banerjee in New Delhi

Opinion  /  Published 28.07.20

The fact of the matter

We read a recent opinion article titled, “An opaque model of drug approval”, in The Telegraph with interest. We respectfully disagree with the author, and appreciate the opportun...
By Sundar Ramanan

Advertisement

Business  /  Published 05.03.20

Nod for Zydus liver drug

Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, known as...
By Vivek Nair in Ahmedabad

Health  /  Published 10.03.20

Anti-HIV drugs for coronavirus-affected Italians

Amid rising coronavirus cases in India, for the first time a combination of two drugs, which is widely used for controlling HIV infection, was administered on an elderly Italian couple undergoing trea...
By PTI in New Delhi

Opinion  /  Published 28.03.19

A rash approach to clinical drug trials

Haste makes waste. This adage can serve as a timely warning for the Drug Controller General of India which has notified the final rules — a draft version was issued last year — to guide clinical t...
By The Editorial Board

India  /  Published 18.04.20

DCGI permits clinical trial of convalescent plasma

The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol develo...
By PTI in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.